Pre-hospital use of ketamine in paediatric trauma

P P Bredmose1, G Grier, G E Davies

  • 1London Helicopter Emergency Medical Service, Department of Pre-hospital Care, The Royal London Hospital, London, UK.

Insights

Ketamine is a safe and effective option for procedural sedation and analgesia in children during pre-hospital emergency care. This review found no major side effects in pediatric patients receiving ketamine for various injuries.

Area of Science:

  • Emergency Medicine
  • Pediatric Critical Care
  • Pharmacology

Background:

  • Pre-hospital care for children requires effective analgesia and sedation.
  • Ketamine offers potential benefits for procedural sedation in pediatric emergencies.

Purpose of the Study:

  • To evaluate the use and safety of ketamine in pediatric patients by a pre-hospital physician-based service.
  • To describe ketamine administration in children under 16 years.

Main Methods:

  • Retrospective database review of 164 pediatric patients (<16 years) treated by London's Helicopter Emergency Medical Service.
  • Analysis of ketamine dosage, route of administration, co-medications, and patient characteristics.

Main Results:

  • Ketamine was administered to children with a median age of 10 years, mostly awake (GCS 15) and non-trapped.
  • Common indications included road traffic collisions, burns, and falls for procedural sedation and analgesia.
  • No significant adverse events like airway loss or oxygen desaturation were observed.

Conclusions:

  • Ketamine appears to be a safe drug for pediatric pre-hospital procedural sedation and analgesia.
  • The safety profile in this setting is reassuring, with rare use in trapped children.
  • Adequate analgesia and sedation are achievable with ketamine in pediatric emergencies.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...